Showing results (1611-1620 of 1,797) with videos related to

Sort By:
Pageof 180
Hepatology Communications|August 8, 2019
Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver DiseasePegah Golabi, Natsu Fukui, James Paik, et al.
Hepatology Communications|August 8, 2019
Lipoprotein Lipase Up-regulation in Hepatic Stellate Cells Exacerbates Liver Fibrosis in Nonalcoholic Steatohepatitis in MiceToshiaki Teratani, Kengo Tomita, Hirotaka Furuhashi, et al.
Hepatology Communications|August 8, 2019
Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct-Acting AntiviralsGeorge N Ioannou, Pamela K Green, Kristin Berry, et al.
Hepatology Communications|November 10, 2018
Outcomes of Pregnancy in Mothers With Cirrhosis: A National Population-Based Cohort Study of 1.3 Million PregnanciesHannes Hagström, Jonas Höijer, Hanns-Ulrich Marschall, et al.
Hepatology Communications|November 10, 2018
Morphometry Confirms Fibrosis Regression From Sustained Virologic Response to Direct-Acting Antivirals for Hepatitis CJason J Pan, Fei Bao, Emma Du, et al.
Hepatology Communications|November 10, 2018
Liver Fibrosis Markers Improve Prediction of Outcome in Non-Acetaminophen-Associated Acute Liver FailureAya Ugamura, Po-Sung Chu, Nobuhiro Nakamoto, et al.
Hepatology Communications|November 10, 2018
Lymphoid Enhancer Factor 1 Contributes to Hepatocellular Carcinoma Progression Through Transcriptional Regulation of Epithelial-Mesenchymal Transition Regulators and Stemness GenesChih-Li Chen, Yu-Shuen Tsai, Yen-Hua Huang, et al.
Hepatology Communications|September 10, 2019
Interleukin-32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin ResistanceNassim Dali-Youcef, Michel Vix, Federico Costantino, et al.
Hepatology Communications|September 10, 2019
A Therapeutic Silencing RNA Targeting Hepatocyte TAZ Prevents and Reverses Fibrosis in Nonalcoholic Steatohepatitis in MiceXiaobo Wang, Mark R Sommerfeld, Kerstin Jahn-Hofmann, et al.
Hepatology Communications|July 24, 2019
Deficient IL-6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and FibrosisPeter Stärkel, Bernd Schnabl, Sophie Leclercq, et al.
Pageof 180